These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 14209763)

  • 1. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Br Med Bull; 1964 Sep; 20():228-32. PubMed ID: 14209763
    [No Abstract]   [Full Text] [Related]  

  • 2. [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].
    DOUGLAS AS; MCNICOL GP
    Recenti Prog Med; 1964 Sep; 37():189-217. PubMed ID: 14229145
    [No Abstract]   [Full Text] [Related]  

  • 3. THROMBOLYTIC THERAPY.
    DOUGLAS AS; MCNICOL GP
    Proc R Soc Med; 1964 Jul; 57(7):609-14. PubMed ID: 14178954
    [No Abstract]   [Full Text] [Related]  

  • 4. CLINICAL TRIAL OF EPSILON-AMINOCAPROIC ACID IN SEVERE HAEMOPHILIA.
    GORDON AM; MCNICOL GP; DUBBER AH; MCDONALD GA; DOUGLAS AS
    Br Med J; 1965 Jun; 1(5451):1632-5. PubMed ID: 14295319
    [No Abstract]   [Full Text] [Related]  

  • 5. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.
    HECKER SP
    Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CURRENT STATUS OF THROMBOLYTIC THERAPY.
    SHERRY S
    Geriatrics; 1964 Sep; 19():628-43. PubMed ID: 14221883
    [No Abstract]   [Full Text] [Related]  

  • 7. STREPTOKINASE AND PULMONARY EMBOLISM.
    BROWSE NL; JAMES DC
    Lancet; 1964 Nov; 2(7368):1039-43. PubMed ID: 14206016
    [No Abstract]   [Full Text] [Related]  

  • 8. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 9. THROMBOLYTIC THERAPY.
    MCNICOL GP; DOUGLAS AS
    J Clin Pathol; 1964 May; 17(3):338-40. PubMed ID: 14159477
    [No Abstract]   [Full Text] [Related]  

  • 10. SOME PROPERTIES OF THE ANTIFIBRINOLYTICALLY ACTIVE ISOMER OF AMINO-METHYLCYCLOHEXANE CARBOXYLIC ACID.
    DUBBER AH; MCNICOL GP; DOUGLAS AS; MELANDER B
    Lancet; 1964 Dec; 2(7373):1317-9. PubMed ID: 14224037
    [No Abstract]   [Full Text] [Related]  

  • 11. STUDIES ON THE MOLECULAR PATHOLOGY AND PATHOGENESIS OF BLEEDING IN SEVERE FIBRINOLYTIC STATES IN DOGS.
    KOWALSKI E; BUDZYNSKI AZ; KOPEC M; LATALLO ZS; LIPINSKI B; WEGRZYNOWICZ Z
    Thromb Diath Haemorrh; 1964 Oct; 12():69-86. PubMed ID: 14224647
    [No Abstract]   [Full Text] [Related]  

  • 12. ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.
    DONALDSON VH
    J Lab Clin Med; 1964 Feb; 63():213-23. PubMed ID: 14125108
    [No Abstract]   [Full Text] [Related]  

  • 13. [THROMBOLYTIC THERAPY. CLINICAL TRIALS OF TREATMENT WITH PURIFIED STREPTOKINASE].
    ABASTADO M
    Bull Mem Soc Med Hop Paris; 1964 Jul; 115():941-57. PubMed ID: 14230879
    [No Abstract]   [Full Text] [Related]  

  • 14. FIBRINOLYTIC THERAPY OF THROMBOEMBOLIC DISEASE.
    COON WW; PENNER JA
    Surg Gynecol Obstet; 1964 Sep; 119():495-502. PubMed ID: 14210147
    [No Abstract]   [Full Text] [Related]  

  • 15. ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE.
    MEYER JS; GILROY J; BARNHART MI; JOHNSON JF
    JAMA; 1964 Aug; 189():373. PubMed ID: 14163124
    [No Abstract]   [Full Text] [Related]  

  • 16. INTERACTION OF STREPTOKINASE AND HUMAN PLASMINOGEN. II. STARCH GEL ELECTROPHORETIC DEMONSTRATION OF A REACTION PRODUCT WITH ACTIVATOR ACTIVITY.
    BARG WF; BOGGIANO E; DERENZO EC
    J Biol Chem; 1965 Jul; 240():2944-50. PubMed ID: 14342318
    [No Abstract]   [Full Text] [Related]  

  • 17. [LEUKOCYTIC FIBRINOLYSIS].
    CAVIEZEL O; VOLLERY M; VANNOTTI A
    Schweiz Med Wochenschr; 1964 Jul; 94():1016-20. PubMed ID: 14243603
    [No Abstract]   [Full Text] [Related]  

  • 18. INACTIVATION OF ACTH BY HUMAN PLASMIN SYSTEM AND EFFECT OF PLASMIN INHIBITORS.
    YAMAMURA Y; KUMAGAI A; TAKEUCHI K; MORIMOTO Y; ASANUMA Y; UEMURA T
    Endocrinol Jpn; 1964 Sep; 11():209-15. PubMed ID: 14279625
    [No Abstract]   [Full Text] [Related]  

  • 19. ACTION OF THE NEW ANTI-FIBRINOLYTIC SUBSTANCE ON THE STREPTOKINASE-ACTIVATED PROTEASES (PLASMINS).
    MIHARA H
    Kobe J Med Sci; 1963 Dec; 18():169-77. PubMed ID: 14160537
    [No Abstract]   [Full Text] [Related]  

  • 20. THE PRESENT STATUS OF FIBRINOLYTIC THERAPY.
    CLIFFTON EE
    Angiology; 1963 Nov; 14():533-41. PubMed ID: 14075024
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.